Alexza Pharmaceuticals Inc. Deferred Revenue
Alexza Pharmaceuticals Inc. had Deferred Revenue of $2.14 million as of 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2016-05-13
- 2016-03-31: Deferred Revenue, Current $2.14M.
- 2015-12-31: Deferred Revenue, Current $2.85M.
- 2015-09-30: Deferred Revenue, Current $2.85M.
- 2015-06-30: Deferred Revenue, Current $2.97M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2016-03-31 | $2.14M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $2.85M 10-Q · filed 2016-05-13 |
| 2015-09-30 | $2.85M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $2.97M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $2.45M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.45M 10-K · filed 2016-03-28 |
| 2014-09-30 | $2.37M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $1.46M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.21M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $2.92M 10-K · filed 2015-03-13 |
| 2013-09-30 | $2.92M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $2.92M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $2.92M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $2.92M 10-K · filed 2014-03-25 |
| 2012-09-30 | $2.92M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $2.92M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $2.92M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $3.76M 10-K · filed 2013-03-26 |
| 2011-09-30 | $2.52M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $3.78M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $4.33M 10-K · filed 2012-03-12 |